Range Advisory, LLC’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Range Advisory, LLC's BMY Position: Q2 2026 in Review
Range Advisory, LLC increased its Bristol-Myers Squibb (BMY) stake by 63% in Q2 2026, buying an estimated $208K and bringing the position to 9,409 shares worth $542K. The position accounts for 0.06% of the portfolio, ranked #155.
Range Advisory, LLC first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Range Advisory, LLC held 9,409 shares of Bristol-Myers Squibb worth $542K as of Q2 2026.
- Range Advisory, LLC bought 3,623 Bristol-Myers Squibb shares in Q2 2026, an estimated $208K.
- Bristol-Myers Squibb made up 0.06% of Range Advisory, LLC's portfolio in Q2 2026, its #155 holding.
- Range Advisory, LLC first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Range Advisory, LLC's 13F filing for Q2 2026, filed 2 Sep 2026.